C83.64 Undifferentiated (diffuse) non-Hodgkin's lymphoma, lymph nodes of axilla and upper limb

Name of the Condition

• Undifferentiated (diffuse) non-Hodgkin's lymphoma, lymph nodes of axilla and upper limb
• Also known as ICD-10 code C83.64

Summary

Undifferentiated (diffuse) non-Hodgkin's lymphoma is a subtype of non-Hodgkin lymphoma characterized by the malignant proliferation of lymphoid cells that lack distinct differentiation or follicular structure. It typically involves abnormal growth of B-cells or T-cells in lymph nodes or other lymphoid tissues, with a diffuse pattern of spread. This condition specifically affects the lymph nodes of the axilla and upper limb and is part of the broader category of non-follicular lymphomas.

Causes

The exact cause of undifferentiated (diffuse) non-Hodgkin's lymphoma remains unknown. It is thought to involve genetic mutations or abnormalities in lymphoid cell development, though specific triggers are not well-defined. Research suggests potential links to immune system dysregulation or prior infections, but no definitive etiology has been established.

Risk Factors

• Age: More common in older adults.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the axilla or upper limb.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI), and biopsy of the affected lymph nodes. Pathological analysis confirms the presence of undifferentiated (diffuse) non-Hodgkin's lymphoma, with further testing to determine the specific subtype and extent of disease. Staging may include additional scans or bone marrow biopsy to assess spread.

Treatment Options

Treatment depends on the subtype, stage, and patient factors. Options may include chemotherapy, immunotherapy, radiation therapy, or targeted therapy. In some cases, a combination of these approaches is used. Treatment plans are individualized based on the patient's overall health and disease characteristics.

Prognosis and Follow-Up

Prognosis varies based on the subtype, stage, and response to treatment. Regular follow-up is essential to monitor for recurrence or progression. Follow-up may include physical exams, imaging, and laboratory tests to assess treatment response and detect any complications.

Complications

Potential complications include disease progression, treatment-related side effects (e.g., infection, fatigue), and organ involvement if the lymphoma spreads. Long-term monitoring is necessary to address these risks.

Lifestyle & Prevention

While prevention is not fully established, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive radiation exposure) may support overall health. Patients should avoid smoking and limit alcohol consumption.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, night sweats, or fatigue. Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

When coding for C83.64, ensure the documentation specifies the involvement of lymph nodes in the axilla and upper limb. Verify that the diagnosis aligns with the characteristics of undifferentiated (diffuse) non-Hodgkin's lymphoma and that no other site-specific codes are more appropriate. Accurate documentation of the anatomical location is critical for correct code assignment.